Cargando…
Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner
[Image: see text] Enteroviruses (family Picornaviridae) comprise a large group of human pathogens against which no licensed antiviral therapy exists. Drug-repurposing screens uncovered the FDA-approved drug fluoxetine as a replication inhibitor of enterovirus B and D species. Fluoxetine likely targe...
Autores principales: | Bauer, Lisa, Manganaro, Roberto, Zonsics, Birgit, Strating, Jeroen R. P. M., El Kazzi, Priscila, Lorenzo Lopez, Moira, Ulferts, Rachel, van Hoey, Clara, Maté, Maria J., Langer, Thierry, Coutard, Bruno, Brancale, Andrea, van Kuppeveld, Frank J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747591/ https://www.ncbi.nlm.nih.gov/pubmed/31305993 http://dx.doi.org/10.1021/acsinfecdis.9b00179 |
Ejemplares similares
-
Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex
por: Hurdiss, Daniel L., et al.
Publicado: (2022) -
Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C
por: Bauer, Lisa, et al.
Publicado: (2020) -
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
por: Bauer, Lisa, et al.
Publicado: (2017) -
Cholesterol: fa(s)t-food for enterovirus genome replication
por: Strating, Jeroen R.P., et al.
Publicado: (2013) -
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
por: Ulferts, Rachel, et al.
Publicado: (2016)